Key information made simple
This study is looking at care and outcomes for people with Treatment-Resistant Depression. Some participants may receive Sham LIFU instead of the study treatment, and direct benefit is not guaranteed.
RecruitingNCT07166289
Ultrasound Neuromodulation of Circuits and Negative Valence Systems in Treatment-Resistant Depression
This study is recruiting. It focuses on depression and currently lists participation information in the United States.
DepressionOtherFrom 18 Years to 65 Years
Your next step
The official record suggests in-person participation through a clinic, with sites including Laureate Institute for Brain Research in Tulsa. Participation appears to involve assessments along with scans or samples to help researchers understand patterns more clearly. The main fit is usually matching the main diagnosis and being able to follow the planned visits or tasks, while common reasons not to take part include pregnancy or breastfeeding and active substance or alcohol problems that could affect the results. The official record does not list a formal phase, which usually means this is focused more on feasibility, delivery, or support than a standard drug-development stage.
Registry reference
This page links back to the public source record so people can verify details directly with the registry and research team.
If you want the full study description, eligibility criteria, locations, and sponsor information in the original format, this is the place to check before taking the next step.
Open source recordAsk HopeStage to review this study with me
This form records your interest so HopeStage can follow up with practical guidance. It is not a medical eligibility decision and it does not guarantee a study spot.
Study reference: NCT07166289. We only ask for your email here. HopeStage can help you review the study, but this is not a medical eligibility decision.
For you
Taking part may help clarify how this condition is measured or understood.
It requires regular visits and structured follow-up.
Requires travel, with in-person participation in United States.
Not medical advice
Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com
Things to check before joining
- Sponsor
- Laureate Institute for Brain Research, Inc.
- Sponsor type
- Research institute
- Main activity
- medication or study treatment
- Time commitment
- multiple visits or assessments
- Study phase
- Not available
- Enrollment
- Not available
- Recruitment status
- Recruiting
- Source
- Official registry link
Questions about this study
What is Ultrasound Neuromodulation of Circuits and Negative Valence Systems in Treatment-Resistant Depression?
This study is exploring medication or study treatment for people with depression. Participants may complete study visits, assessments, or follow-up activities defined by the research team. It includes a comparison with a sham comparison. Direct benefit is not guaranteed.
Who is behind this study, and what type of sponsor is it?
This study is sponsored by Laureate Institute for Brain Research, Inc.. Based on the sponsor name or official registry information, it appears to be a research institute. You should verify the details in the official registry record.
What does participation involve, what phase is it, and what should I ask about safety?
This study may involve medication or study treatment, study visits, and assessments. The time commitment is multiple visits or assessments. The study phase is not available in HopeStage data. Check the official source record to see whether a phase is listed. Enrollment is not available in HopeStage data. HopeStage cannot say whether a study is safe or right for you. Before joining, ask the research team about possible risks, time commitment, visits, side effects, compensation, safety monitoring, and whether participation may affect your current care.
Where can I verify the study details?
Use the official source record linked on this page to check the full study description, recruitment status, eligibility criteria, locations, sponsor information, phase, enrollment, contact details, and any listed risks or requirements.